我国首批商用重水堆产锶-89成功出堆

Core Insights - The successful production of Strontium-89 from the "Hefei-1" heavy water reactor marks a significant advancement in China's capability for the independent production of medical isotopes, enhancing the country's self-sufficiency in this field [1][2] Group 1: Medical Isotope Production - Strontium-89 is an important medical isotope used for alleviating bone pain caused by metastatic cancer, significantly improving patient quality of life [1] - Previously, China had some capacity for Strontium-89 production but relied heavily on imports to meet market demand [1] - The successful production of Strontium-89 is a key outcome of the "Hefei-1" technology, which lays a solid technical foundation for the large-scale and stable production of various medical isotopes, including Lutetium-177 and Yttrium-90 [1] Group 2: Future Prospects - The Qinshan Nuclear Power Base will continue to explore the resource and technical potential of heavy water reactors to accelerate the large-scale production of related medical isotopes [2] - This initiative aims to elevate China's nuclear technology application industry to a higher level [2]